Cite
HARVARD Citation
Diener, H. et al. (2021). Efficacy, tolerability, and safety of eptinezumab in patients with a dual diagnosis of chronic migraine and medication‐overuse headache: Subgroup analysis of PROMISE‐2. Headache. 61 (1), pp. 125-136. [Online].